Conforma Reduce™
Topical DCA serum
A topical alternative to Kybella
The at-home alternative to Kybella.
Same active. No downtime.
Conforma Reduce™ delivers the same Deoxycholic Acid used in Kybella injections, applied topically at home. Skip the twenty injections, the week of bruising, and the $4,200 bill.
Why patients switch from Kybella to Conforma Reduce™
Same active. Different delivery.
A meaningful difference in cost, comfort, and access.
Kybella and Conforma Reduce™ share the same active compound — Deoxycholic Acid (DCA). Kybella injects it. Conforma Reduce™ delivers it topically using Conformational Change™ Technology, which restructures the DCA molecule at the nano scale so it can pass through the skin barrier and reach the subcutaneous fat layer where it works.
-
No needles. No recovery week.
Kybella requires twenty or more injections per session, followed by five to seven days of visible swelling and bruising. Many patients don't return for their second session because of the recovery burden.
Conforma Reduce™ takes thirty seconds to apply, has zero downtime, and is a treatment patients actually complete.
-
$210 vs. $4,200+ for a full course.
A full Kybella cycle costs between $4,200 and $6,300 across two to three sessions. Conforma Reduce™ delivers the same active compound at home for $210 per bottle.
One bottle is sized for an 8-week treatment course. No clinic visits, no injector fees, no surprise costs.
The evidence
The Clinical Evidence
Conforma Reduce™ was tested in a controlled 8-week clinical study conducted at a South Korean research center, with results measured via advanced 3D Vectra XT imaging — the same instrumentation used in Kybella's REFINE pivotal trials.
Week 4
Visible fat reduction.
3D Vectra XT imaging confirmed measurable reduction in chin surface area and volume by week 4 of daily application.
Skin Research and Technology, 2023 View Before & After Gallery
Week 8
Statistically significant improvement.
Continued reduction at 8 weeks with statistically significant decrease in submental fullness compared to placebo (p < 0.05).
Skin Research and Technology, 2023 View Before & After Gallery
Full study
Zero adverse effects.
No skin irritation, no downtime, no adverse effects across all 42 participants over 8 weeks of twice-daily application.
Skin Research and Technology, 2023 View Before & After Gallery
Conforma Reduce™
A topical breakthrough in submental contouring and jawline definition. Conforma Reduce™ targets persistent lower-face fullness using Deoxycholic Acid, the same active found in professional injectable treatments, without the needles.
Powered by Conformational Change™ Technology developed in a South Korean research laboratory, the formula reaches the subcutaneous fat layer where DCA works, visibly sculpting and defining over 30 to 60 days of twice-daily application at home.
Side by side
Conforma Reduce™ vs. Kybella.
| Conforma Reduce™ | Kybella | |
|---|---|---|
| Active ingredient | Deoxycholic Acid (DCA) | Deoxycholic Acid (DCA) |
| Delivery method | Topical serum at home | 20+ injections in-clinic |
| Downtime | None | 5–7 days swelling & bruising |
| Cost per course | $210 | $4,200–$6,300 |
| Sessions required | Twice daily, 8 weeks | 2–3 in-clinic sessions |
| Where to buy | Direct-to-consumer | Prescription only, in-clinic |
| Clinically studied | Yes, published 2023 | REFINE-1 and REFINE-2 |
Kybella vs. Conforma Reduce™ FAQs
Does Conforma Reduce™ actually work like Kybella?
Yes. Both treatments use Deoxycholic Acid to reduce submental fat cells. Kybella delivers DCA via injection directly into the submental area. Conforma Reduce™ delivers the same active topically using Conformational Change™ Technology, which restructures the DCA molecule at the nano scale so it passes through the skin barrier and reaches the subcutaneous fat layer. A 42-participant clinical study published in Skin Research and Technology in 2023 confirmed statistically significant submental reduction at 4 and 8 weeks of twice-daily application.
Why does Kybella cost so much more than Conforma Reduce™?
Kybella is a prescription pharmaceutical administered in a clinical setting by a licensed injector. A single Kybella session uses approximately three vials at $700 each, totaling around $2,100 per session. Most patients need two to three sessions to see full results, bringing the total course cost to $4,200 to $6,300. Conforma Reduce™ delivers the same active compound at home for $210 per bottle — no clinic visits, no injector fees, no procedural overhead.
What are the side effects of Conforma Reduce™ compared to Kybella?
Kybella typically causes significant bruising and swelling under the chin for approximately one week per session. Many patients cover the treated area with scarves or turtlenecks during recovery. Conforma Reduce™ may cause a slight tingle during application and has zero downtime. The published 2023 clinical study reported zero adverse effects across the full treatment period.
How long until I see results with Conforma Reduce™ compared to Kybella?
Kybella results typically appear four to six weeks after each injection session, with most patients needing multiple rounds spaced four to six weeks apart. Conforma Reduce™ users see first visible tightening around week 2 of twice-daily application, with meaningful submental reduction by week 4. Full results for most users emerge at 4 to 8 weeks of consistent use.
Can I use Conforma Reduce™ if I have already started Kybella?
Yes. Many patients use Conforma Reduce™ between Kybella sessions to extend the active treatment window, or after a full Kybella course as ongoing maintenance. Consult your treating clinician before combining treatments.
Do I need a prescription for Conforma Reduce™?
No. Conforma Reduce™ is a cosmetic topical product available direct-to-consumer through conformationalaesthetics.com. No prescription, no in-clinic appointment, and no injector required.
Is Conforma Reduce™ FDA-approved like Kybella?
Conforma Reduce™ is a cosmetic product, and cosmetics are not FDA-approved — that's true of every over-the-counter skincare product on the U.S. market. Kybella is a prescription pharmaceutical, which is a different regulatory category. The active compound in both products (Deoxycholic Acid) has decades of clinical evidence behind it in injectable form. Conforma Reduce™ was tested in its own controlled clinical study, published in a peer-reviewed journal in 2023.
The evidence
Clinically Proven.
Peer-Reviewed. Published.
Two independent clinical studies, conducted at the PNK Skin Research Center in Seoul. Two peer-reviewed publications in international dermatology journals. Gold-standard measurement equipment, IRB approval, Helsinki Declaration compliance. Here’s what the studies measured.
